Meera Srivastava

Title: Meera Srivastava: Innovator in Cancer Research

Introduction

Meera Srivastava is a prominent inventor based in Potomac, MD (US). She has made significant contributions to the field of cancer research, particularly in developing therapeutic agents for treating specific types of cancers. With a total of 3 patents to her name, her work is paving the way for innovative treatments.

Latest Patents

One of her latest patents focuses on inhibitors for ERG oncogene positive cancers. Alterations to the ERG gene are among the most significant genomic changes associated with various cancers, including prostate cancer. This invention provides selective inhibitors of wild type or altered ERG protein expression, serving as therapeutic agents for treating ERG positive cancers. Another notable patent is for a knockout mouse for the tumor suppressor gene ANX7. This invention outlines methods for assessing the prognosis of breast cancer patients and identifying probabilities related to metastasis and survival. It also includes assay complexes that utilize prostate and breast tissue samples to enhance diagnostic accuracy.

Career Highlights

Meera Srivastava is affiliated with the Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. Her work at this institution has allowed her to focus on groundbreaking research that addresses critical health challenges.

Collaborations

Throughout her career, Meera has collaborated with esteemed colleagues, including Harvey B Pollard and Clifton L Dalgard. These partnerships have contributed to the advancement of her research and the development of innovative solutions in cancer treatment.

Conclusion

Meera Srivastava's contributions to cancer research through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to inspire advancements in therapeutic approaches for cancer treatment.